|5Mar 30, 2:04 PM ET

Orgenesis Inc. 5

5 · Orgenesis Inc. · Filed Mar 30, 2017

Insider Transaction Report

Form 5
Period: 2016-11-30
Caplan Vered
Director
Transactions
  • Award

    Stock Option (Right to Buy Common Stock)

    2016-04-27+1,104,9504,443,235 total
    Exercise: $0.00From: 2016-04-27Exp: 2026-04-27Common Stock (1,104,950 underlying)
Footnotes (1)
  • [F1]On April 27, 2016, the Board granted Ms. Caplan fully vested options for 1,104,950 shares at the exercise price of $0.001 per share.

Documents

1 file
  • 5
    doc1.xmlPrimary

    FORM 5